Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Announcements
Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

Drawing of a brain with the title Understanding Glioblastoma
Understanding Glioblastoma
Glioblastoma is the most aggressive primary brain cancer in adults. Even with treatment, just over 6 percent of patients survive five years or more. But there's good news: GW Cancer Center researchers are bringing hope for more precise, less invasive, and more effective treatments.
Dr Puchalski, Dr. Bauman, Dr. Goyal
GW Cancer Center and SMHS Celebrate Academic Excellence and Patient Care with Endowed Professorship Installations
Sharad Goyal and Christina Puchalski were honored for their groundbreaking contributions to advancing cancer treatment and spiritual care in clinical medicine.
photo of Sara Richman, LICSW
Five Questions with Sara Richman, LICSW, OSW-C
Sara Richman found her calling early, volunteering on a crisis hotline as a teen. Now an oncology social worker, she’s still driven by the same instinct: to connect, to listen, and to help. When she’s not supporting patients, you’ll probably find her at a concert. She’s been hooked on live music…